6:07 PM
 | 
Oct 22, 2012
 |  BC Extra  |  Financial News

Stemline changes IPO range

Stemline Therapeutics Inc. (New York, N.Y.) amended its IPO and now plans to sell 1.8 million shares at $10-$12. An $11 price would raise $20 million and value the company at...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >